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Underlying Pathophysiology. References 
Additional Sources 
Eosinophilic esophagitis is a chronic 
disease with long-term persistence of 
esophageal inflammation (Schuval & 
Gold, 2013, p. 20).  Timely recognition 
and diagnosis is key to reducing the 
impact that long-term irritation by 
eosinophilic infiltration plays on the 
esophagus.  As nurses are very often on 
the front-line of history taking and 
information gathering on a patient, it is 
important to recognize the signs of 
reflux-like symptoms that are either 
refractory to, or slow to respond to 
traditional reflux therapies (such as the 
use of PPIs).  Many times, nurses for 
whatever reason are privy to information 
that is not always divulged from the 
patient to the primary care giver.  Careful 
analysis of provoking/relieving factors 
must be made. 
     Eosinophilic esophagitis (EE) is 
differentiated from Gastroesophageal 
Reflux Disease (GERD) by endoscopic 
and histopathologic examination.  The 
hallmark of EE is eosinophilic infiltration 
of the esophagus.  EE has been defined as 
“a clinicopathologic entity, combining 
clinical data on (1) relevant symptoms 
(distinct in the pediatric or adult 
populations with mostly food impaction 
and dysphagia in adults and feeding 
intolerance, failure to thrive, and GERD 
symptoms in children); (2) esophageal 
biopsies with adequate histologic 
findings in the esophageal biopsies (>15 
eosinophils/high power field [HPF]); and 
(3) exclusion of other diseases with 
overlapping features, especially GERD” 
(Genevay, Rubbia-Brandt, & Rougemont, 
2010, p.816). 
     Under normal circumstances, the 
esophageal mucosa is devoid of resident 
eosinophils, however there are certain 
disease states in which eosinophils 
infiltrate into and accumulate within the 
esophageal mucosa.  EE and GERD are 
two of these disease states, with lower 
numbers of infiltrating eosinophils in 
GERD, and more numerous eosinophils in 
EE.   
     Although the etiology of EE is not 
fully established, for whatever reason 
there is an infiltration/migration of 
eosinophils into the esophageal mucosa.  
There is strong evidence that points 
towards an IgE-mediated allergic 
reaction, with the offending agent being 
either a food allergen or an aeroallergen 
(inhaled).  There also seems to be a 
correlation between asthma and EE, as 
evidenced by the high numbers of EE 
patients who also suffer from asthma. 
     The effects that eosinophils play on 
the esophageal mucosa are multiple.  In 
general, the effects are proinflammatory 
and include the upregulation of adhesion 
systems, and the mediation of cell 
trafficking through the release of various 
cytokines, chemokines, and lipid 
mediators.  The tissue damage and 
dysfunction that results from the release 
of cationic proteins results in fibrosis of 
the esophagus.  Toxic granule proteins 
are released that cause further mast cell 
degranulation, resulting in a vicious cycle 
of inflammation and tissue damage 
(Swoger, et al, 2007, p.1542). 
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Implications for 
Nursing Care 
A 4 month old girl presents with colic, 
feeding irritability and copious vomiting 
that is refractory to H2R antagonists 
(Zantac), as well as dietary changes from 
breast milk to a soy-based formula.  
Medical history at time of presentation 
includes URI and asthma (wheezing).  At 
age 6 months, she is switched from 
Zantac to Prevacid, and formula is 
switched to one with pre-digested milk 
proteins.  During this time, a slow, yet 
steady improvement in feeding habits 
and a reduction in the amount of 
vomiting are noticed, yet symptoms do 
persist. 
A Case Study:  Eosinophilic Esophagitis vs 
GERD in children 
Gastroenterology referral is made at the 
1 year mark but an appointment cannot be 
made for another 6 months.  During this 
time, subtle improvements are made 
through the dietary elimination of  all milk 
products but signs of reflux still persist (i.e. 
vomiting and slow weight-gain).  By two 
years of age, the toddler undergoes an 
esophagogastroduodenoscopy to rule out 
other causes of her GI symptoms.  
Treatment continues with PPI (Prevacid) 
until the patient is 4 years of age, at which 
she is weaned from pharmacologic agents 
and exhibits resolution of GI symptoms. 
Sign and Symptoms of Eosinophilic 
Esophagitis in Children 
As the pathophysiology of EE 
demonstrates a strong relationship 
between either food, or aeroallergens, 
prompt recognition of the offending 
allergen is crucial.  The multi-faceted 
complications from this disease require a 
multi-disciplinary approach, which 
should consist of:  gastroenterologist 
consultation, along with consultation 
from both a dietician and a specialist in 
allergy/immunology.  Once an individual 
is diagnosed with EE, every effort must 
be made to identify the offending 
allergen.  Dietary management then 
becomes a major focus of treatment.  
Known as the “six food elimination diet”, 
the removal of the six most common 
allergenic foods (milk, soy, egg, wheat, 
peanut/tree nuts, fish/shellfish) has 
shown a promising effect on the 
symptomatic relief of patients with EE.  
According to a study found in 
Contemporary Pediatrics, 74% of 
patients with EE showed histopathologic 
improvements after implementation of 
the six food elimination diet (Schuval & 
Gold, 2013, p.17).  If diagnosed and 
properly treated in a timely manner, the 
long term sequelae caused from EE such 
as esophageal strictures and small-
caliber esophagus may be avoided. 
•Nausea 
•Recurrent Vomiting 
•Weight Loss 
•Failure to Thrive 
•Anemia 
•Choking 
•Feeding Disturbances 
•Irritability 
•Abdominal Pain 
*Note the multiple overlaps that 
correlate with the symptoms of 
Gastroesophageal Reflux Disease.   
Histopathologic slide showing eosinophilic infiltration of esophageal tissue. 
     Swoger, et al have proposed a 
method of eosinophil recruitment to 
the normally eosinophil-devoid 
esophagus involving interleukin(IL) 5 
and procedes as such:  The cytokine 
IL-5, produced by T-helper type II 
lymphocytes primes eosinophils to 
react to chemoattracts such as 
eotaxin.  IL-5 also promotes the 
eosinophil’s development, as well as 
activation, migration, and effector 
functions.  Furthermore, IL-5 is 
overexpressed, and this systemic 
overexpression may directly promote 
migration of the eosinophils to the 
esophagus.  The presence of an 
increased number of mast cells and T 
cells in the esophagus of EE patients 
has also been documented (Swoger, 
et al, 2007, p.1543).  Eotaxin 
promotes eosinophil accumulation 
and adhesion to the esophageal 
endothelium by way of vascular cell 
adhesion molecule (CAM) 1, present 
on the surface of endothelial tissues 
and has also been found to be 
overexpressed in patients with EE 
(Swoger, et al, 2007, p.1543) 
     Another cytokine, cytokine IL-13, 
which upregulates IgE, is important 
for eosinophil survival, and activates 
adhesion systems also plays a role.  
Studies have proven a dysregulation 
of IL-13 in several allergic disorders 
such as asthma, atopic dermatitis, 
and allergic rhinitis (Swoger, et al, 
2007, p.1543).  This lends credibility 
to the proposed link between EE and 
an allergic (IgE-mediated) 
provocation. 
     To lend further evidence to the 
allergy-associated theory, it has been  
reported that “approximately 80% of 
pediatric patients with EE had a 
positive skin test result to a panel of 
food allergens and aeroallergens” 
(Swoger, et al, 2007, p.1543). 
     It is important to note, however, 
that a direct correlation does not 
always exist between a positive food 
allergy test result and the 
development of EE.  Some patients 
continue to have symptoms even 
after foods that were positive on 
traditional allergy testing are 
eliminated (Swoger, et al, 2007, 
p.1543).   
    Several foods have been identified 
as being most-problematic for 
patients with EE.  These foods are 
rich in protein and the classic 
examples include:  milk, eggs, soy-
beans, corn, wheat, chicken, and nuts 
(Swoger, et al, 2007, p.1543).  Recall 
the patient in the case study who 
failed to show a positive response to 
a soy-based formula. 
     It is important to note, however, 
that the provoking allergen, whether 
food or aeroallergen may not be a 
pure IgE  mediated reaction and that 
not all allergens are identifiable by 
traditional skin-prick testing.  For 
this reason, EE has been described 
by some as a polygenic allergy 
disorder.  Signs of an IgE-mediated 
allergic reaction, such as type-I 
histamine-mediated reactions (in 
which a reaction occurs within 
minutes of exposure to the allergen), 
may coexist with a delayed 
hypersensitivity reaction that may 
occur hours to days after the 
exposure to the offending antingen 
(Swoger, et al, 2007, p.1543).  
     Inhaled (aero) allergens are 
thought to play a role in the 
infiltration of the esophageal mucosa 
as well, as pulmonary exopsure to 
these inahled antigens may result in 
esophageal mast cell activation, 
resulting in the release of cytokines 
that further activates the 
inflammatory response.  Additionaly, 
the aeroallergens may be swallowed 
after being transported from the 
lung to the oropharynx by a ciliary 
mechanism where they can then 
provoke cytokine production in the 
esophagus. 
     The combined data on both food 
and aeroallergens “suggest 2 
possible mechanisms of disease in 
EE.  There might be initial 
sensitization due to a food antigen, 
with EE occurring on esophageal re-
challenge with the same antigen.  
Alternatively, there might be initial 
bronchial sensitization followed by 
esophageal rechallenge” (Swoger, et 
al, 2007, p. 1454). 
Conclusion 
     Although the symptoms of GERD 
are shared by those of eosinophilic 
esophagtitis, for the most part, the 
resemblances stop here.  Treatment of 
GERD is largely focused on the 
pharmacologic use of PPIs and H2R 
antagonists.  EE is in large part 
refractory to these agents.  Treatment 
modalities for EE are labor-intensive 
and require a multi-disciplinary team 
of gastreoenterologists, allergists, and 
dieticians for effective management.  
Prompt recognition and early 
treatment of EE vs. GERD leads to an 
overall improvement in the quality of 
life of an individual with EE.  The 
saying “time is tissue”, although 
routinely used in terms of a cardiac 
setting, also very much so applies to 
eosinophilic esophagitis. 
Top:  barium swallow showing 
esophageal strictures in EE.  
Bottom:  endoscopic image 
showing trachealization of the 
esophagus in EE.  
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